BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23437365)

  • 1. Olanzapine treatment of adolescent rats causes enduring specific memory impairments and alters cortical development and function.
    Milstein JA; Elnabawi A; Vinish M; Swanson T; Enos JK; Bailey AM; Kolb B; Frost DO
    PLoS One; 2013; 8(2):e57308. PubMed ID: 23437365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function.
    Vinish M; Elnabawi A; Milstein JA; Burke JS; Kallevang JK; Turek KC; Lansink CS; Merchenthaler I; Bailey AM; Kolb B; Cheer JF; Frost DO
    Int J Neuropsychopharmacol; 2013 Aug; 16(7):1599-609. PubMed ID: 23351612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats.
    Lian J; Pan B; Deng C
    Pharmacol Rep; 2016 Oct; 68(5):1028-35. PubMed ID: 27428765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System.
    De Santis M; Lian J; Huang XF; Deng C
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27879654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T; Meltzer HY; Ichikawa J
    J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
    Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY
    J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.
    Zhang W; Bymaster FP
    Psychopharmacology (Berl); 1999 Jan; 141(3):267-78. PubMed ID: 10027508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of central activation of serotonin 5-HT2A/2C or dopamine D 2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test.
    Feng M; Gao J; Sui N; Li M
    Psychopharmacology (Berl); 2015 Apr; 232(7):1219-30. PubMed ID: 25288514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment.
    Wang HD; Deutch AY
    Neuropsychopharmacology; 2008 May; 33(6):1276-86. PubMed ID: 17687264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of dopamine D₂/D₃ and serotonin 5-HT₂A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography.
    Nakazawa S; Yokoyama C; Nishimura N; Horisawa T; Kawasaki A; Mizuma H; Doi H; Onoe H
    Psychopharmacology (Berl); 2013 Jan; 225(2):329-39. PubMed ID: 22868411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.
    Volonté M; Monferini E; Cerutti M; Fodritto F; Borsini F
    J Neurochem; 1997 Jul; 69(1):182-90. PubMed ID: 9202309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
    J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action.
    Mocci G; Jiménez-Sánchez L; Adell A; Cortés R; Artigas F
    Neuropharmacology; 2014 Apr; 79():49-58. PubMed ID: 24211653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
    Tarazi FI; Zhang K; Baldessarini RJ
    Psychopharmacology (Berl); 2002 May; 161(3):263-70. PubMed ID: 12021829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens.
    Xu S; Gullapalli RP; Frost DO
    Schizophr Res; 2015 Feb; 161(2-3):452-7. PubMed ID: 25487700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain.
    Kusumi I; Takahashi Y; Suzuki K; Kameda K; Koyama T
    J Neural Transm (Vienna); 2000; 107(3):295-302. PubMed ID: 10821438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.